Microbiology and Biospecimen Core

$335,784P01FY2014HLNIH

University Of Wisconsin-Madison, Madison WI

Investigators

Linked publications & trials

Paper 39244418 Paper 37638498 Paper 37098126 Paper 33964299 Paper 33535024 Paper 33434532 Paper 33357024 Paper 33176330 Paper 33091409 Paper 32997571 Paper 32620559 Paper 32380068 Paper 32130954 Paper 31980848 Paper 31182091 Paper 31163174 Paper 31036433 Paper 30916989 Paper 30661310 Paper 30659817 Paper 30658930 Paper 30578265 Paper 30320550 Paper 30269957 Paper 30261051 Paper 30212648 Paper 29790784 Paper 29760811 Paper 29399473 Paper 29374573 Paper 29307657 Paper 29296089 Paper 29176665 Paper 29121479 Paper 29111214 Paper 28987219 Paper 28843541 Paper 28472984 Paper 28384123 Paper 28327377 Paper 28192616 Paper 28183432 Paper 28160357 Paper 28137494 Paper 28030377 Paper 28027280 Paper 28018912 Paper 28011059 Paper 27942592 Paper 27797613 Paper 27743961 Paper 27653379 Paper 27609657 Paper 27511920 Paper 27484037 Paper 27458992 Paper 27373325 Paper 27312820 Paper 27232888 Paper 27027959 Paper 26972576 Paper 26960297 Paper 26947980 Paper 26947979 Paper 26772925 Paper 26595729 Paper 26474238 Paper 26399222 Paper 26194546 Paper 26145984 Paper 26100591 Paper 25979524 Paper 25874939 Paper 25865368 Paper 25848009 Paper 25747786 Paper 25724434 Paper 25678088 Paper 25439354 Paper 25261313 Paper 25261307 Paper 25213041 Paper 25116239 Paper 24984695 Paper 24904537 Paper 24789198 Paper 24698319 Paper 24675858 Paper 24675857 Paper 24675855 Paper 24636091 Paper 24636084 Paper 24569522 Paper 24475177 Paper 24471509 Paper 24314639 Paper 24236893 Paper 24187656 Paper 24125148 Paper 23992536

Abstract

The Microbiology and Biospecimen Core (MicroBio Core) is established to provide viral and bacterial diagnostics, purified human rhinovirus (HRV) preparations, and cultured primary airway and nasal epithelial cells to each of the three proposed projects. The Core will provide support to Project II of this Program renewal application with the capability to identify all common respiratory viruses in samples of airway secretions and determine the individual species/type/strain of HRV. The quantity of selected bacterial pathogens {Moraxella catanrhalis, Hemophilus influenza and Streptococcus pneumoniae) in serial nasal lavage or sputum samples will be determined by multiplex qPCR, and partial sequencing will be used to determine whether bacteria that are sequentially detected represent a single strain (colonization) or serial infections with distinct strains. In addition, this Core will support the experiments of Projects l-lll by supplying (1) high-titer and uniform HRV virus stocks (2) antibodies targeting specific HRV proteins, (3) cultures of primary airway and nasal epithelial cells, and by (4) performing standardized HRV infectivity assays (plaque and TCID50) and quantitative RT-PCR and (5) infecting nasal epithelial cell cultures with HRV. In addition to fulfilling these aims, the MicroBio Core will also provide expertise for the use of these reagents and viral and bacterial diagnostic assays to COAST personnel and other collaborating investigators, and be available for consultation regaring molecular identification of respiratory viruses and bacteria, molecular biology of HRVs and the use of primary human airway epithelial cells.

View original record on NIH RePORTER →